Biotech

All Articles

Lykos 'remorses' not making known research study offenses with author

.Psychopharmacology has actually taken 3 articles regarding midstage medical trial data evaluating L...

Analysts examine Avidity's DMD succeed, uncovering distinctions in data

.Avidity Biosciences satisfied entrepreneurs along with period 1/2 records in Duchenne muscular dyst...

Actinogen's cortisol blocker falls short stage 2 clinical depression study

.Actinogen Medical's cortisol blocker has actually skipped the key endpoint of a phase 2 research st...

Bivictrix determines going private only technique to take ADC in to center

.Antibody-drug conjugates (ADCs) have actually gone to the center of many a billion-dollar biobuck l...

TPG tops up funds to $580M for investments across lifestyle scientific researches

.Resource supervisor TPG, which has actually supported biotechs like Sionna Therapeutics and also Sa...

Merck stops phase 3 TIGIT test in bronchi cancer cells for impossibility

.Merck &amp Co.'s TIGIT course has endured yet another setback. Months after shuttering a phase 3 mo...

After a hard year, Exscientia folds in to Recursion

.After a year determined through pipe cuts, the shift of its own CEO as well as discharges, Exscient...

Cullinan, after $25M deal, return bispecific to Harbour

.Cullinan Therapy was wowed good enough with Harbour BioMed's bispecific invulnerable reactor that i...

A more detailed consider Strong Biotech's Brutal 15

.In this particular week's episode of "The Leading Pipe," our company're diving into Tough Biotech's...

Lilly experiences phase 2 failure of tau-targeting med

.The confetti is still flying coming from Eli Lilly's celebration commemorating the approval of Alzh...